Search research articles
Contact Us
Filters
Showing results (101-110 of 168) with videos related to
Page
of 17
Sort By:
Cancer Immunology, Immunotherapy : CII
|
September 22, 2000
Killing of Fas ligand-resistant renal carcioma cells by interleukin-2- and BCG-activated effector cells
S Brandau, H Suttmann, H D Flad, et al.
BJU International
|
February 15, 2000
The immunohistochemical assessment of occult regional lymph node metastases in patients with T3pN0M0 prostate cancer before definitive radiotherapy
H Clobes, S D Fossâ, H Waehre, et al.
Khirurgiia
|
January 1, 1989
[The current status and place of open surgery in treating urolithiasis]
P G Fabricius, D Jocham, B Liedl, et al.
Der Urologe. Ausg. A
|
May 1, 1983
[Prostate cytology. 12 years' experience with transrectal fine needle biopsy]
D Jocham, E Schmiedt, H Göttinger, et al.
Helvetica Chirurgica Acta
|
November 1, 1990
[NMR tomography of vena cava thrombi: clinical significance in the differential diagnosis and therapy]
B Liedl, H Schmidt, B Mayr, et al.
Der Urologe. Ausg. A
|
March 1, 1989
[Fluorescence diagnosis of porphyrin-marked urothelial tumors. Status of experimental development]
D Jocham, R Baumgartner, N Fuchs, et al.
Urology
|
February 20, 2004
Elevation of CA 19-9 in giant hydronephrosis induced by a renal calculus
A Meyer, I Kausch, S Krüger, et al.
European Urology
|
April 14, 2005
Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma
I Kausch, H Jiang, B Thode, et al.
Urology
|
May 1, 1984
Extracorporeal shock-wave lithotripsy (ESWL) for treatment of urolithiasis
C Chaussy, J Schüller, E Schmiedt, et al.
Der Urologe. Ausg. A
|
April 22, 2005
[Combination treatment with antisense oligonucleotides and chemotherapy in vitro]
I Kausch, N Ewerdwalbesloh, H Jiang, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 168) with videos related to
Sort By:
Page
of 17
Cancer Immunology, Immunotherapy : CII
|
September 22, 2000
Killing of Fas ligand-resistant renal carcioma cells by interleukin-2- and BCG-activated effector cells
S Brandau, H Suttmann, H D Flad, et al.
BJU International
|
February 15, 2000
The immunohistochemical assessment of occult regional lymph node metastases in patients with T3pN0M0 prostate cancer before definitive radiotherapy
H Clobes, S D Fossâ, H Waehre, et al.
Khirurgiia
|
January 1, 1989
[The current status and place of open surgery in treating urolithiasis]
P G Fabricius, D Jocham, B Liedl, et al.
Der Urologe. Ausg. A
|
May 1, 1983
[Prostate cytology. 12 years' experience with transrectal fine needle biopsy]
D Jocham, E Schmiedt, H Göttinger, et al.
Helvetica Chirurgica Acta
|
November 1, 1990
[NMR tomography of vena cava thrombi: clinical significance in the differential diagnosis and therapy]
B Liedl, H Schmidt, B Mayr, et al.
Der Urologe. Ausg. A
|
March 1, 1989
[Fluorescence diagnosis of porphyrin-marked urothelial tumors. Status of experimental development]
D Jocham, R Baumgartner, N Fuchs, et al.
Urology
|
February 20, 2004
Elevation of CA 19-9 in giant hydronephrosis induced by a renal calculus
A Meyer, I Kausch, S Krüger, et al.
European Urology
|
April 14, 2005
Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma
I Kausch, H Jiang, B Thode, et al.
Urology
|
May 1, 1984
Extracorporeal shock-wave lithotripsy (ESWL) for treatment of urolithiasis
C Chaussy, J Schüller, E Schmiedt, et al.
Der Urologe. Ausg. A
|
April 22, 2005
[Combination treatment with antisense oligonucleotides and chemotherapy in vitro]
I Kausch, N Ewerdwalbesloh, H Jiang, et al.
Page
of 17